<DOC>
	<DOCNO>NCT02979717</DOCNO>
	<brief_summary>The objective study determine effect high protein , high fiber supplement pre-load energy intake subsequent meal compare low fiber , high carbohydrate Control product healthy overweight obese subject . The investigator hypothesize high protein , high fiber pre-load result reduce energy intake subsequent meal compare low protein , low fiber .</brief_summary>
	<brief_title>The Effect High Protein , High Fibre Shake Pre-load Measures Satiety Subsequent Energy Intake</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<criteria>1 . Male nonpregnant , nonlactating female , 1850 year age , inclusive 2 . Body mass index ( BMI ) 27 33 kg/mÂ² inclusive screening . 3 . Blood pressure &lt; 130/85 . 4 . Willing maintain habitual diet , physical activity pattern , body weight throughout trial . 5 . Willing abstain strenuous exercise , consumption alcoholic drink caffeinecontaining food/drinks 24 hour study day study day ( study completion day ) . 6 . Willing maintain current dietary supplement ( applicable ) use throughout trial . On test day , subject agrees take dietary supplement dismissal GI lab . Failure comply result reschedule test visit . 7 . Absence health condition would prevent fulfillment study requirement judge Investigator basis medical history . 8 . Understanding study procedure willing provide inform consent participate study authorization release relevant protect health information study investigator . 9 . Female subject willing use contraceptive method avoid pregnancy study period . 1 . Failure meet one inclusion criterion 2 . Smokers 3 . Known history AIDS , hepatitis , history presence clinically important endocrine ( include Type 1 Type 2 diabetes mellitus ) , cardiovascular ( include , limited , atherosclerotic disease , history myocardial infarction , peripheral arterial disease , stroke ) , pulmonary , biliary GI disorder . 4 . Use medication know influence carbohydrate metabolism , gastrointestinal function appetite , include , limited adrenergic blocker , blood thinner , diuretic , thiazolidinediones , metformin , antibiotic systemic corticosteroid within 4 week screen visit , condition might , opinion Dr. Wolever , president GI lab , either : 1 ) make participation dangerous subject others , 2 ) affect result . 5 . Major trauma surgical event within 3 month screen . 6 . Unwillingness inability comply experimental procedure follow GI Labs safety guideline . 7 . Known intolerance , sensitivity allergy ingredient study product . 8 . Extreme dietary habit , judge Investigator ( i.e . Atkins diet , high protein diet , etc ) .. 9 . Change body weight &gt; 3.5kg within 4 week screen visit . 10 . Presence sign symptom active infection within 5 prior test visit . If infection occur study period , test visit reschedule sign symptom resolve treatment ( i.e . antibiotic therapy ) complete least 5 prior test visit . 11 . History cancer prior two year , except nonmelanoma skin cancer . 12 . Exposure nonregistered drug product within 30 prior screening . 13 . Pregnancy breastfeed 14 . Any history eat disorder ( e.g. , anorexia nervosa , bulimia nervosa , binge eat ) diagnose health professional</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>satiety</keyword>
	<keyword>protein</keyword>
	<keyword>fiber</keyword>
</DOC>